Floatz logo

1H-INDOLE-1-CARBOXYLIC ACID, OCTAHYDRO-4-HYDROXY-4-((3-METHYLPHENYL)ETHYNYL)-, METHYL ESTER, (3AR,4S,7AR)-

Huntington's Disease

Novartis PharmaceuticalsSmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

25 Active assets in the Huntington's Disease cohort.

Asset / SponsorPhaseRating
Deutetrabenazine
Teva Branded Pharmaceutical Products R&D LLC
Phase 4BBB
Tetrabenazine
William Ondo, MD
Phase 4BBB
ro7234292
Hoffmann-La Roche
Phase 3BBB
Dimebon
Medivation, Inc.
Phase 3BB
Pridopidine
Prilenia
Phase 3BB

View all 50 →

Same molecule, other indications

1H-INDOLE-1-CARBOXYLIC ACID, OCTAHYDRO-4-HYDROXY-4-((3-METHYLPHENYL)ETHYNYL)-, METHYL ESTER, (3AR,4S,7AR)- is also rated in:

drug-induced dyskinesiaDormant
BBB
Indicative ·
72 / 100
View asset →
movement disorderDormant
BB
Indicative ·
67 / 100
View asset →
Parkinson diseaseDormant
B
Indicative ·
61 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →